Search results for "PHARMACOLOGY & PHARMACY"

showing 10 items of 329 documents

Ion-pair approach coupled with nanoparticle formation to increase bioavailability of a low permeability charged drug.

2018

Abstract Atenolol is a drug widely used for the treatment of hypertension. However, the great drawback it presents is a low bioavailability after oral administration. To obtain formulations that allow to improve the bioavailability of this drug is a challenge for the pharmaceutical technology. The objective of this work was to increase the rate and extent of intestinal absorption of atenolol as model of a low permeability drug, developing a double technology strategy. To increase atenolol permeability an ion pair with brilliant blue was designed and the sustained release achieved through encapsulation in polymeric nanoparticles (NPs). The in vitro release studies showed a pH-dependent relea…

Drugmedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological Availability02 engineering and technology030226 pharmacology & pharmacyIntestinal absorptionPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug Delivery SystemsPolylactic Acid-Polyglycolic Acid CopolymerIn vivoOral administrationmedicineAnimalsRats WistarAntihypertensive Agentsmedia_commonChromatographyChemistryBenzenesulfonates021001 nanoscience & nanotechnologyAtenololControlled releaseBioavailabilityPLGADrug LiberationAtenololIntestinal AbsorptionNanoparticles0210 nano-technologymedicine.drugInternational journal of pharmaceutics
researchProduct

Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Carbamazepine.

2020

Abstract Literature relevant to assessing whether BCS-based biowaivers can be applied to immediate release (IR) solid oral dosage forms containing carbamazepine as the single active pharmaceutical ingredient are reviewed. Carbamazepine, which is used for the prophylactic therapy of epilepsy, is a non-ionizable drug that cannot be considered “highly soluble” across the range of pH values usually encountered in the upper gastrointestinal tract. Furthermore, evidence in the open literature suggests that carbamazepine is a BCS Class 2 drug. Nevertheless, the oral absolute bioavailability of carbamazepine lies between 70 and 78% and both in vivo and in vitro data support the classification of ca…

Drugmedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological Availability02 engineering and technologyBioequivalencePharmacology030226 pharmacology & pharmacyDosage formBiopharmaceuticsExcipients03 medical and health sciences0302 clinical medicineIVIVCTherapeutic indexmedicineImmediate releasemedia_commonActive ingredientDosage Formsbusiness.industryCarbamazepine021001 nanoscience & nanotechnologyCarbamazepineSolubilityTherapeutic Equivalency0210 nano-technologybusinessmedicine.drugJournal of pharmaceutical sciences
researchProduct

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Cephalexin Monohydrate.

2019

Literature data and results of experimental studies relevant to the decision to allow waiver of bioequivalence studies in humans for the approval of immediate release solid oral dosage forms containing cephalexin monohydrate are presented. Solubility studies were performed in accordance with the current biowaiver guidelines of the Food and Drug Administration, World Health Organization and European Medicines Agency, taking the degradation at some pH values into consideration. Together with solubility and permeability data for cephalexin monohydrate from the literature, it was demonstrated to be a Biopharmaceutics Classification System Class 1 drug. The pharmacokinetic behavior, results of b…

Drugmedia_common.quotation_subjectPharmaceutical ScienceExcipientAdministration OralBiological Availability02 engineering and technologyBioequivalencePharmacology030226 pharmacology & pharmacyDosage formPermeabilityBiopharmaceutics03 medical and health sciences0302 clinical medicinemedicineBiopharmaceutics Classification System (BCS)HumansRegulatory scienceLADME characteristicsmedia_commonActive ingredientcephalexin monohydrateDosage FormsbioequivalenceCephalexinexcipientsbusiness.industryBiopharmaceutics021001 nanoscience & nanotechnologyBiopharmaceutics Classification SystemSolubilityTherapeutic Equivalencyregulatory science0210 nano-technologybusinessmedicine.drugJournal of pharmaceutical sciences
researchProduct

Patterns and trends in scientific research on generic drugs

2016

[Purpose]: The purpose of this study to investigate the evolution and current status of peer-reviewed publications concerning generic drugs during the past few decades. [Methods]: Scientific articles about generic drugs published until 2012 were retrieved through the PubMed/MEDLINE database, and a content analysis was performed. [Findings]: Our study revealed an increasing number of publications on generics since 1984. Statins, antiretroviral therapies, and antiepileptics, followed by immunosuppressants and antithrombotic agents, were the most common therapeutic drug categories. [Implications]: Almost 60% of the generics detailed in studies indexed in MEDLINE were acting on the cardiovascul…

Drugmedicine.medical_specialtyATC classification systemmedia_common.quotation_subjectAlternative medicineMEDLINEPharmacology030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineAntithromboticmedicineDrugs GenericHumansGeneric drugsPharmacology (medical)030212 general & internal medicineIntensive care medicinemedia_commonPharmacologyPeer Review Researchbusiness.industryResearchDrugs genericPubMed/MedlinePeriodicals as TopicMedline databasebusinessContent analysis
researchProduct

Amorphous Ropinirole-Loaded Mucoadhesive Buccal Film: A Potential Patient-Friendly Tool to Improve Drug Pharmacokinetic Profile and Effectiveness

2020

Nowadays the therapeutic strategies to manage Parkinson&rsquo

Drugtherapy optimizationparkinson’s diseasemedia_common.quotation_subjectPeppas-Salhin model.Medicine (miscellaneous)orocomucosal filmslcsh:MedicinePeppas-Salhin model02 engineering and technologyPharmacology030226 pharmacology & pharmacyDosage formArticleorocomucosal film03 medical and health sciencesdissolution kinetic0302 clinical medicinebuccal administrationPharmacokineticsOral administrationSettore MED/28 - Malattie OdontostomatologicheMucoadhesionMedicineEudragit® L100media_commonbusiness.industrylcsh:Rex vivo permeationBuccal administration021001 nanoscience & nanotechnologynervous system diseasesropiniroleRopiniroleSettore CHIM/09 - Farmaceutico Tecnologico Applicativo0210 nano-technologybusinessDrug metabolismdissolution kineticsmucoadhesionmedicine.drug
researchProduct

Statistical tools and control of internal lubricant content of inhalation grade HPMC capsules during manufacture

2016

The internal lubricant content (ILC) of inhalation grade HPMC capsules is a key factor to ensure good powder release when the patient inhales a medicine from a dry powder inhaler (DPI). Powder release from capsules has been shown to be influenced by the ILC. The characteristics used to measure this are the emitted dose, fine particle fraction and mass median aerodynamic diameter. In addition the ILC level is critical for capsule shell manufacture because it is an essential part of the process that cannot work without it. An experiment has been applied to the manufacture of inhalation capsules with the required ILC. A full factorial model was used to identify the controlling factors and from…

Dry powder inhaler (DPI)Materials scienceChemistry PharmaceuticalPharmaceutical ScienceNanotechnologyCapsulesOleic Acids02 engineering and technology030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineHypromellose DerivativesAdministration InhalationAerodynamic diameterHPMC capsulesLubricantskin and connective tissue diseasesLubricantsFactorial modelModels StatisticalInhalationDry Powder Inhalers021001 nanoscience & nanotechnologyHypromellose DerivativesDry-powder inhalerbody regionsAerosolizationInternal lubricantLinear models0210 nano-technologyMATEMATICA APLICADABiomedical engineeringParticle fraction
researchProduct

Lenalidomide induced reversible parkinsonism, dystonia, and dementia in subclinical Creutzfeldt-Jakob disease

2018

DystoniaPediatricsmedicine.medical_specialtybusiness.industryParkinsonismPrion diseaseDiseaseParkinsonismmedicine.disease030226 pharmacology & pharmacyCreutzfeldt-Jakob disease03 medical and health sciences0302 clinical medicineNeurologymedicineDementiaNeurology (clinical)businessLenalidomide030217 neurology & neurosurgerySubclinical infectionLenalidomidemedicine.drugJournal of the Neurological Sciences
researchProduct

Investigation of Different Iontophoretic Currents Profiles for Short-Term Applications in Cosmetics.

2018

[EN] This study aimed at investigating the effect of electrical current profile upon the iontophoretic transport of (i) ascorbic acid (AA) and (ii) ellagic acid (EA), into porcine skin in vitro, and the impact of the physicochemical properties of both actives on their mechanism of transport when formulated in cosmetic compositions. The experiments were performed using a proprietary iontophoretic device containing a roller to apply the formulation. Three current profiles were tested: (i) galvanic direct current (DC), (ii) square unipolar pulse current (SPC), and (iii) galvanic direct current (DC) + pulse current (PC). The skin samples were collected at different sampling points, extracted an…

Ellagic acidMaterials scienceTopical penetrationPharmaceutical Sciencelcsh:RS1-441Galvanic currentSquare unipolar pulse current030226 pharmacology & pharmacyElectromigrationArticlelcsh:Pharmacy and materia medica030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicinetopical penetrationellagic acidgalvanic currentGalvanic cellPulsed currentActive ingredientChromatographyIontophoresisDirect currentsquare unipolar pulse currentPenetration (firestop)IontophoresisiontophoresisAscorbic acidchemistryAscorbic acidascorbic acidpulsed currentEllagic acidPharmaceutics
researchProduct

Commentary on the MID3 Good Practices Paper

2017

During the last 10 years the European Medicines Agency (EMA) organized a number of workshops on modeling and simulation, working towards greater integration of modeling and simulation (M&S) in the development and regulatory assessment of medicines. In the 2011 EMA - European Federation of Pharmaceutical Industries and Associations (EFPIA) Workshop on Modelling and Simulation, European regulators agreed to the necessity to build expertise to be able to review M&S data provided by companies in their dossier. This led to the establishment of the EMA Modelling and Simulation Working Group (MSWG). Also, there was agreement reached on the need for harmonization on good M&S practices and for conti…

Engineeringbusiness.industryHarmonizationPublic relations030226 pharmacology & pharmacyManagement03 medical and health sciences0302 clinical medicineConsistency (negotiation)Documentation030220 oncology & carcinogenesisModeling and SimulationAgency (sociology)Pharmacology (medical)Dialog boxbusinessDrug industryCPT: Pharmacometrics & Systems Pharmacology
researchProduct

Towards ductilization of high strength 7XXX aluminium alloys via microstructural modifications obtained by friction stir processing and heat treatmen…

2021

Abstract High strength 7XXX aluminium series reach exceptional strength, higher than all other industrial aluminium alloys. However, they suffer from a lack of ductility compared to softer series. This work presents a procedure to improve the ductility of 7475 Al alloy in high strength condition, reaching a true fracture strain of 70% at full 500 MPa T6 yield strength. Using friction stir processing (FSP) and post-FSP heat treatments, 100% of industrial rolled material T6 yield stress is maintained but a 180% increase in fracture strain is measured for the processed material. This ductility improvement is studied by in-situ synchrotron X-ray tomography and is explained by the reduction of i…

Equiaxed crystalsFriction stir processingMaterials scienceAlloyIntermetallicchemistry.chemical_element02 engineering and technologyengineering.material030226 pharmacology & pharmacy[SPI.MAT]Engineering Sciences [physics]/Materials03 medical and health sciences0302 clinical medicineAluminiumFormabilityGeneral Materials ScienceComposite materialDuctilityMicrostructureCrack propagationPhysicsDuctilizationAluminium alloysFriction stir processing (FSP)021001 nanoscience & nanotechnologyMicrostructurechemistryengineering0210 nano-technology
researchProduct